AZ rejected on the Seroquel’s flexible application of PMS cases for children
The flexible application of the post-marketing surveillance(PMS) for the AstraZeneca’s schizophrenia treatment, ‘Seroquel(generic name: quetiapine),’ was rejected. The issue was the number of cases targeting children and the youth.
According to the data unveiled by the Ministry of Food and Drug ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
